王建铭,王琦光,朱鲜阳

• 1:中国人民解放军北部战区总医院全军心血管病研究所先心病内科

摘要(Abstract)：

<正>随着小儿心脏外科诊断技术和手术治疗的飞速发展,愈来愈多的先天性心脏病(先心病)患儿的生存状态得到改善并且长大成人。1972年在第45届美国心脏病学会年会上创建了成人先天性心脏病(adult congenital heart disease, ACHD)新的亚专业学科~([1]),使小儿先心病演变至ACHD,同时也见证着医学领域的发展。新近,《2020年欧洲心脏病学会(European Society of Cardiology,ESC)ACHD管理指南》~([2])(以下简称《2020ESC ACHD指南》)颁布,对2010年版指南~([3])进行了指导性的修订和有意义的更新。现结合我国ACHD管理实践对《2020 ESC ACHD指南》予以解读。

关键词(KeyWords)： 先天性心脏病;成人;欧洲心脏病学会

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 王建铭,王琦光,朱鲜阳

参考文献(References)：

• [1]Perloff J,Child J,Aboulhosn J.Congenital Heart Disease in Adults.3rd Edition.Singapore:Elsevier Saunders,2008.
• [2]Baumgartner H,De Backer J,Babu-Narayan SV,et al.2020ESC Guidelines for the management of adult congenital heart disease.Eur Heart J,2020.[Online ahead of print]
• [3]Baumgartner H,Bonhoeffer P,De Groot NM,et al.ESCGuidelines for the management of grown-up congenital heart disease(new version 2010).Eur Heart J,2010,31(23):2915-2957.
• [4]Moons P,Bovijn L,Budts W,et al.Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium.Circulation,2010,122(22):2264-2272.
• [5]中华人民共和国卫生部.中国出生缺陷防治报告（2012).2012.http：//www.gov.cn/gzdt/att/att/site1/20120912/1c6f6506c7f811ba cf9301.pdf
• [6]Ntiloudi D,Giannakoulas G,Parcharidou D,et al.Adult congenital heart disease:A paradigm of epidemiological change.Int J Cardiol,2016,218:269-274.
• [7]Marelli AJ,Ionescu-Ittu R,Mackie AS,et al.Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.Circulation,2014,130(9):749-756.
• [8]Baumgartner H,Budts W,Chessa M,et al.Recommendations for organization of care for adults with congenital heart disease and for training in the subspecialty of‘Grown-up Congenital Heart Disease’in Europe:a position paper of the Working Group on Grown-up Congenital Heart Disease of the European Society of Cardiology.Eur Heart J,2014,35(11):686-690.
• [9]van der Bom T,Mulder BJM,Meijboom FJ,et al.Contemporary survival of adults with congenital heart disease.Heart,2015,101(24):1989-1995.
• [10]Regitz-Zagrosek V,Roos-Hesselink JW,Bauersachs J,et al.2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.Eur Heart J,2018,39(34):3165-3241.
• [11]Baggen VJM,van den Bosch AE,Eindhoven JA,et al.Prognostic value of N-terminal pro-B-type natriuretic peptide,troponin-T,and growth-differentiation factor 15 in adult congenital heart disease.Circulation,2017,135(3):264-279.
• [12]Van De Bruaene A,Hickey EJ,Kovacs AH,et al.Phenotype,management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure.Int J Cardiol,2018,252:80-87.
• [13]Kapel GF,Reichlin T,Wijnmaalen AP,et al.Re-entry using anatomicaly determined isthmuses:a curable ventricular tachycardia in repaired congenital heart disease.Circ Arrhythm Electrophysiol,2015,8(1):102-109.
• [14]Priori SG,Blomstr?m-Lundqvist C,Mazzanti A,et al.2015ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology(ESC).Endorsed by:Association for European Paediatric and Congenital Cardiology(AEPC).Eur Heart J,2015,36(41):2793-2867.
• [15]Khairy P,Van Hare GF,Balaji S,et al.PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease:developed in partnership between the Pediatric and Congenital Electrophysiology Society(PACES) and the Heart Rhythm Society(HRS).Endorsed by the governing bodies of PACES,HRS,the American College of Cardiology(ACC),the American Heart Association(AHA),the European Heart Rhythm Association(EHRA),the Canadian Heart Rhythm Society(CHRS),and the International Society for Adult Congenital Heart Disease(ISACHD).Can J Cardiol,2014,30(10):e1-e63.
• [16]Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Europace,2016,18(11):1609-1678.
• [17]Simonneau G,Montani D,Celermajer DS,et al.Haemodynamic definitions and updated clinical classification of pulmonary hypertension.Eur Respir J,2019,53(1):1801913.
• [18]Diller GP,K?rten MA,Bauer UM,et al.Current therapy and outcome of eisenmenger syndrome:data of the German National Register for congenital heart defects.Eur Heart J,2016,37(18):1449-1455.
• [19]Yang H,Bouma BJ,Dimopoulos K,et al.Non-vitamin Kantagonist oral anticoagulants(NOACs) for thromboembolic prevention,are they safe in congenital heart disease?Results of a worldwide study.Int J Cardiol,2020,299:123-130.
• [20]Baumgartner H,Falk V,Bax JJ,et al.2017 ESC/EACTSGuidelines for the management of valvular heart disease.Eur Heart J,2017,38(36):2739-2791.
• [21]Pujol C,Niesert AC,Engelhardt A,et al.Usefulness of direct oral anticoagulants in adult congenital heart disease.Am JCardiol,2016,117(3):450-455.